Update on progress of legislation to allow the continued sale of, and access to, medicines, medical devices and clinical trials.

The Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 and The Human Medicines (Amendment) Regulations 2019 were debated and passed by a committee in the House of Commons last week.

Guidance on operational changes
Leaving the EU with a deal remains the Government’s top priority. This has not changed. However, a responsible government must plan for every eventuality, including a no-deal scenario. We are continuing with our no-deal planning to ensure we are fully prepared.

To support your preparations for a no-deal EU exit we are publishing guidance on operational changes on GOV.UK.

MHRA Update please click here

MHRA Guidance Pack please click here

Note to TAs and SRMs please click here

 

Latest Opportunities

Funding competition for digital therapeutics for mental health

UK registered businesses can apply for a share of up to £3.7m for R&D projects…

AI Airlock pilot call for applications

Funding competition information Following the launch webinar on 23 July 2024, candidates can now apply…

Explore the Chinese Market with EFEC

Lily Lin, CEO of Excellence First Enterprise Consultancy (EFEC), will be visiting China from 13…

Latest News

V Formation expands digital marketing capabilities with new hire

Nottingham-based marketing and PR agency, V Formation, has bolstered its digital marketing offering with the…

Interactive Software shares guide to data migration

Your data is one of your most valuable assets. Poor data quality can lead to…

Med-Di-Dia launches new Fractional Regulatory Service

The new service from Med-Di-Dia enables its specialists to act as ad-hoc support for various…